Ibalizumab Shows Antiviral Activity Against Multidrug-Resistant HIV In Phase III Trial.

August 16, 2018

MedPage Today (8/15, Walker) reports researchers found in a phase III trial that Trogarzo (ibalizumab), “a monoclonal antibody treatment against HIV, showed significant antiviral activity against multidrug-resistant HIV infection.” The findings were publ...